new post
StocksRunner logo
mail
search
 
menu
 
Viridian Therapeutic
$32.28
+0.53%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

VRDN Stock Analysis & IQ Rating | Viridian Therapeutic

 
 
 

VRDN

 

Viridian Therapeutic

$32.28

 
+$0.17 | +0.53%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$34.02
 
 
MKT CAP
$3.08B
 
52W Low
$9.9
 
 
VOL
$403.58K
 
P/E Ratio
N/A
 
 
AVG VOL
$1.76M
 
RSI
60.17
 
 
TREND
Uptrend
 
 
 

BQ Stock IQ

 
lock  Login to see Viridian Therapeutic (VRDN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

VRDN Target Price

 
 
 

Strengths

 
 

VRDN Rewards

 Upgraded on attractively valued

VRDN Rewards

 Outperform the market

VRDN Rewards

 Investors confidence is positive

 
 

VRDN Price Performance

 
 

$31.72   (+1.77%)

$21.58   (+49.58%)

$16.86   (+91.46%)

$18.2   (+77.36%)

 
 
1year
6month
3month
1month
 

VRDN Risk Level

 
 

VRDN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
VRDN Risk Level
Low
LOW
HIGH
 

VRDN Analysts Opinion

 

VRDN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

VRDN Earnings Sentiment

 Earnings decline YoY

VRDN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

VRDN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 

VRDN Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

VRDN Future Sentiment

 Outperform the market

 
 

VRDN Analysts Opinion

VRDN Analysts opinion is positive and also has improved from the past 3 months

 

VRDN Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
NA
100%
 

VRDN Street Sentiment 

VRDN Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

VRDN Performance Sentiment

 
Sentiments overview associated with VRDN events and the stock performance.
 
 
78%
22%
Positive
Negative
7 out of 9
events present
2 out of 9
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$32.11
 
Resistance
Price
 
$27.08
 
 
Current Price Range
 
$33.03
 
 
Show methods +
 
 
VRDN Latest Analysis +
 
 
FAQ About VRDN Stock Insights
 

What is VRDN current stock price?

What are VRDN stock strengths?

What is VRDN Risk Level?

What is VRDN market cap and volume?

What is VRDN current Stock IQ?

Should I buy VRDN stock right now?

Is VRDN a Strong Buy right now?

What does a 'Strong Buy' rating mean for VRDN?

What does a 'Strong Sell' rating mean for VRDN?

What factors influence VRDN's Stock IQ?

 
 
StocksRunner

Explore our VRDN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored VRDN Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our VRDN Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner Overview
 
StocksRunner Trending
 
StocksRunner Screener
 
StocksRunner Insights
 
StocksRunner Top Rated
 
StocksRunner Momentum
 
StocksRunner Leaders
mail
 
 
 

VRDN

 

Viridian Therapeutic

 
 

Current Price

 

$32.28

 
+$0.17 | +0.53%
 
 
52W High
$34.02
 
 
MKT CAP
$3.08B
 
52W Low
$9.9
 
 
VOL
$403.58K
 
P/E Ratio
N/A
 
 
AVG VOL
$1.76M
 
RSI
60.17
 
 
TREND
Uptrend
 
 
 
Set Alerts
  
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 

Target Price

 
 
 
 
Not Enough Information
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

VRDN Rewards

 Upgraded on attractively valued

VRDN Rewards

 Outperform the market

VRDN Rewards

 Investors confidence is positive

 
 
 
 
user
 
 
 
 

VRDN Price Performance

 
 

$31.72   (+1.77%)

$21.58   (+49.58%)

$16.86   (+91.46%)

$18.2   (+77.36%)

 
 
1year
6month
3month
1month
 

VRDN Analysts Opinion

 

VRDN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

 
 
 

Earnings

×
 

Earnings

 

VRDN Earnings Sentiment

 Earnings decline YoY

VRDN Earnings Sentiment

 Above analyst estimates

 
 

Rating

×
 

Rating

 

VRDN Rating Sentiment

 Upgraded on attractively valued

 

Momentum

×
 

Momentum

 
 

Activity

×
 

Activity

 

VRDN Activity Sentiment

 Investors confidence is positive

 

Future

×
 

Future

 

VRDN Future Sentiment

 Outperform the market

 
 

VRDN Analysts Opinion

VRDN Analysts opinion is positive and also has improved from the past 3 months

 

VRDN Street Sentiment

 

Analysts perspectives on the stock desirability, trend direction and growth potential

 
 
78%
Buy
Opinion
Trend
Score
Potential
Score
 
Consensus Rating
 
100%
NA
100%
 

VRDN Street Sentiment 

VRDN Street Sentiment is extremely bullish and have positive views on the near-term outlook

 

VRDN Risk Level

 
 

VRDN has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

 
 
 
VRDN Risk Level
Low
LOW
HIGH
 
VRDN Performance Sentiment
 
Sentiments overview associated with VRDN events and the stock performance.
 
 
78%
22%
Positive
Negative
7 out of 9
events present
2 out of 9
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

Technical Price Levels

 

Average key support and resistance price levels

 
 
Support
Price
 
$32.11
 
Resistance
Price
 
$27.08
 
 
Current Price Range
 
$33.03
 
 
Show methods +
 
 
 
 
 
 

VRDN Stock IQ

 
 
 
lock  Login to unlock Viridian Therapeutic (VRDN) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

VRDN Latest Analysis

 
 
 

FDA Accepts Viridians Veligrotug BLA For Priority Review In Thyroid Eye Disease . (RTTNews) - Viridian Therapeutics Inc. (VRDN) announced that the FDA has accepted its Biologics License Application for Veligrotug proposed for the treatment of thyroid eye disease for priority review with a decision expected by June 30 2026.

 

Tue Dec 23, 2025

$32.11 | -1.11%
 
Activity

Argenx Flops As Viridian Celebrates On Surprise Setback For Vyvgart Powerhouse. Argenx stock toppled Monday after the biotech scrapped plans to develop its blockbuster drug Vyvgart for thyroid eye disease.The post Argenx Flops As Viridian Celebrates On Surprise Setback For Vyvgart Powerhouse appeared first on Investor'.s Business Daily.

 

Mon Dec 15, 2025

$33.03 | +2.23%
 
Activity

Argenx Halts Phase 3 Thyroid Eye Disease Trial Peers Like Viridian Therapeutics To Benefit. ) on Monday announced it would discontinue the Phase 3 UplighTED studies evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with moderate to .The decision is based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the trials for futility following its review of data from a pre-.Efgartigimod showed a favorable safety and tolerabil

 

Mon Dec 15, 2025

$33.03 | +2.23%
 
Activity
Activity

Wedbush Maintains Viridian Therapeutics (VRDN) Outperform Recommendation. Fintel reports that on December 10 2025 Wedbush maintained coverage of Viridian Therapeutics (NasdaqCM:VRDN) with a Outperform recommendation. Analyst Price Forecast Suggests 27.74% Upside

 

Wed Dec 10, 2025

$32.60 | +2.52%
 
Potential
Rating
 
 
 
 
 
StocksRunner

Discover VRDN Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of VRDN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our VRDN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VRDN Stock trends

VRDN Stock performance

VRDN Stock analysis

VRDN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

VRDN Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing VRDN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing VRDN

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.